Lisa D. Earnhardt, President and CEO at Intersect ENT, Inc. (XENT), sold 59,176 shares at $28.43 ($1.7M) on 2019-04-15, disclosed to the SEC on 2019-04-17.
Seasonal sale ($1.7M) by President and CEO — this insider has traded XENT in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.43 | 29,588 | $841K | 50.0% |
| 2 | $28.43 | 29,588 | $841K | 50.0% |
| Total | $28.43 avg | 59,176 | $1.7M | 100% |
| Filing → |
| ABT | SELL | 2024-03-04 | $82K | — | Filing → |
| ABT | SELL | 2023-03-02 | $190K | — | Filing → |
| ABT | SELL | 2022-03-02 | $223K | — | Filing → |